Autoimmune & immunology · Phase III

Top sponsors

• Takeda 39 programs
• Janssen-Cilag International N.V 26 programs
• Anaxis Pharma 20 programs
• AbbVie 18 programs
• Novartis India 17 programs
• AbbVie Deutschland GmbH 13 programs
• HOFFMANN-LA ROCHE 11 programs
• Eli Lilly and 9 programs
• Chinese Academy of 8 programs
• Bristol-Myers Squibb Australia 7 programs
• PARItec 7 programs
• Pacira Ireland 7 programs

1. TAK-279-3001

   Takeda

   Moderate to Severe Plaque Psoriasis

   phase 3 · small molecule · active

   1 trial →

2. TAK-279-3002

   Takeda

   Moderate to Severe Plaque Psoriasis

   phase 3 · small molecule · active

   1 trial →

3. TAK-279-PsA-3001

   Takeda

   Psoriatic Arthritis

   phase 3 · small molecule · active

   1 trial →

4. TAK-279-PsA-3002

   Takeda

   Active Psoriatic Arthritis Stratified by Prior Biologic Use

   phase 3 · small molecule · active

   1 trial →

5. TAK-279-PsA-3003

   Takeda

   Psoriatic Arthritis

   phase 3 · small molecule · active

   1 trial →

6. TAK-279-PsO-3004

   Takeda

   Moderate to Severe Plaque Psoriasis

   phase 3 · small molecule · active

   1 trial →

7. TD-1473 Dose A

   Theravance Biopharma Ireland Umited

   Ulcerative Colitis (UC)

   phase 3 · small molecule · terminated

   2 trials →

8. TILD-19-07

   Lacuna Pharma Pty Ltd

   Psoriatic Arthritis

   phase 3 · small molecule · active

   1 trial →

9. TILD-19-12

   Lacuna Pharma Pty Ltd

   Treatment of pediatric subjects with moderate to severe chronic plaque psoriasis

   phase 3 · small molecule · active

   1 trial →

10. TILD-19-19

    Lacuna Pharma Pty Ltd

    Psoriatic Arthritis

    phase 3 · small molecule · active

    1 trial →

11. TILD-24-01

    Lacuna Pharma Pty Ltd

    Moderate to Severe Genital Psoriasis

    phase 3 · small molecule · active

    1 trial →

12. Tacrolimus

    Takeda

    Ulcerative Colitis

    phase 3 · small molecule · terminated

    1 trial →

13. Tacrolimus capsule

    Astellas Pharma Inc

    Myasthenia Gravis

    phase 3 · small molecule · completed

    1 trial →

14. Tacrolimus capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Myasthenia Gravis

    phase 3 · small molecule · completed

    1 trial →

15. Tacrolimus capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    phase 3 · small molecule · completed

    1 trial →

16. Telitacicept

    Vor Biopharma

    Systemic Lupus Erythematosus

    phase 3 · mab · terminated

    2 trials →

17. Telitacicept

    Vor Biopharma

    Generalized Myasthenia Gravis

    phase 3 · mab · active

    1 trial →

18. The STARS trial

    The George Institute

    juvenile idiopathic arthritis

    phase 3 · small molecule · active

    1 trial →

19. Tocilizumab 162 mg

    Hoffmann-La Roche

    Rheumatoid Arthritis

    phase 3 · small molecule · completed

    1 trial →

20. Tofacitinib 5 mg BID

    Pfizer

    Psoriatic Arthritis

    phase 3 · small molecule · completed

    1 trial →

21. Topical roflumilast

    Arcutis Biotherapeutics

    Chronic Plaque Psoriasis

    phase 3 · small molecule · completed

    1 trial →

22. Treatment of TongBi Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    phase 3 · small molecule · active

    1 trial →

23. Upadacitinib

    AbbVie

    Crohn's Disease

    phase 3 · small molecule · active

    2 trials →

24. Upadacitinib

    AbbVie

    Spondyloarthritis

    phase 3 · small molecule · completed

    1 trial →

25. Upadacitinib

    AbbVie

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

26. Upadacitinib

    AbbVie

    Systemic Lupus Erythematosus

    phase 3 · small molecule · active

    1 trial →

27. Upadacitinib (ABT-494)

    AbbVie

    Ulcerative Colitis (UC)

    phase 3 · small molecule · active

    1 trial →

28. Ustekinumab

    The First People's Hospital of Lianyungang

    Crohn Disease

    phase 3 · small molecule · active

    1 trial →

29. Ustekinumab Dose Based on BSA and Body Weight

    Janssen Cilag International NV

    Colitis, Ulcerative

    phase 3 · small molecule · completed

    1 trial →

30. VAY736F12301E1

    Novartis Pharmaceuticals

    Systemic Lupus Erythematosus

    phase 3 · small molecule · active

    1 trial →

31. VIB0551.P3.S1

    Elan Pharma International

    Myasthenia Gravis which is either due to acetylcholine receptor antibodies (AChR) or muscle specific kinase antibodies (MuSK).

    phase 3 · small molecule · active

    1 trial →

32. VISIPAQUE d’I/mL for Knee OsteoArthritis

    Pari Pharma GmbH

    Knee OsteoArthritis

    phase 3 · small molecule · active

    1 trial →

33. VX-509

    Vertex Pharmaceuticals (Australia) Pty.

    Rheumatoid Arthritis

    phase 3 · small molecule · completed

    3 trials →

34. Vedolizumab

    Takeda

    Ulcerative Colitis

    phase 3 · small molecule · completed

    9 trials →

35. Vedolizumab

    Takeda

    Colitis, Ulcerative

    phase 3 · small molecule · completed

    5 trials →

36. Vedolizumab 300 mg IV

    Takeda

    Colitis, Ulcerative

    phase 3 · small molecule · completed

    1 trial →

37. Vedolizumab IV

    Takeda

    Moderately to Severely Active Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

38. Vedolizumab IV

    Takeda

    Crohn's Disease (CD)

    phase 3 · small molecule · active

    1 trial →

39. Vedolizumab IV

    Takeda

    Crohn's Disease

    phase 3 · small molecule · active

    2 trials →

40. Vedolizumab IV

    Takeda

    Ulcerative Colitis

    phase 3 · small molecule · active

    4 trials →

41. Vedolizumab SC

    Takeda

    Ulcerative Colitis

    phase 3 · small molecule · active

    1 trial →

42. Vedolizumab SC

    Takeda

    Colitis, Ulcerative

    phase 3 · small molecule · completed

    1 trial →

43. Vedolizumab SC 108 mg

    Takeda

    Crohn's Disease

    phase 3 · small molecule · completed

    1 trial →

44. VedolizumabSC-3003

    Takeda

    Active Ulcerative Colitis or Crohn’s Disease

    phase 3 · small molecule · active

    1 trial →

45. VedolizumabSC-3004

    Takeda

    Ulcerative Colitis or Crohn’s Disease

    phase 3 · small molecule · active

    1 trial →

46. Vitamin D3

    Hospital Authority, Hong Kong

    Lupus Erythematosus, Systemic

    phase 3 · small molecule · completed

    1 trial →

47. Voclosporin

    Aurinia Pharmaceuticals

    Lupus Nephritis

    phase 3 · small molecule · completed

    3 trials →

48. Voclosporin

    Aurinia Pharmaceuticals

    Adolescent Lupus Nephritis

    phase 3 · small molecule · terminated

    2 trials →

Frequently asked questions